PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24184387-4	2014	Administration of deferoxamine or KC7F2 to hypoxic microglial cells enhanced extracellular signal-regulated kinase (ERK) phosphorylation (p-ERK), but decreased the phosphorylation of p38 (p-p38).	Deferoxamine	18-30	mitogen-activated protein kinase 1	Mus musculus	77-114	
24184387-4	2014	Administration of deferoxamine or KC7F2 to hypoxic microglial cells enhanced extracellular signal-regulated kinase (ERK) phosphorylation (p-ERK), but decreased the phosphorylation of p38 (p-p38).	Deferoxamine	18-30	mitogen-activated protein kinase 1	Mus musculus	116-119	
24184387-4	2014	Administration of deferoxamine or KC7F2 to hypoxic microglial cells enhanced extracellular signal-regulated kinase (ERK) phosphorylation (p-ERK), but decreased the phosphorylation of p38 (p-p38).	Deferoxamine	18-30	mitogen-activated protein kinase 1	Mus musculus	140-143	
35237325-0	2022	Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1alpha, Wnt/beta-Catenin, and p38MAPK/ERK Pathways.	Deferoxamine	0-12	mitogen-activated protein kinase 1	Mus musculus	131-134	
35237325-8	2022	In conclusion, DFO inhibited the proliferation and ALL xenograft tumor growth, obstructed the cell cycle, and induced apoptosis of ALL cells, probably via inactivating the ROS/HIF-1alpha, Wnt/beta-catenin, and p38MAPK/ERK signaling.	Deferoxamine	15-18	mitogen-activated protein kinase 1	Mus musculus	218-221	
26996132-8	2016	We further revealed that DFO treatment significantly inhibited the MPTP-induced phosphorylation of the c-Jun N-terminal kinase (JNK) and differentially enhanced the phosphorylation of extracellular regulated protein kinases (ERK) and mitogen-activated protein kinase (MAPK)/P38 kinase.	Deferoxamine	25-28	mitogen-activated protein kinase 1	Mus musculus	184-223	
26996132-8	2016	We further revealed that DFO treatment significantly inhibited the MPTP-induced phosphorylation of the c-Jun N-terminal kinase (JNK) and differentially enhanced the phosphorylation of extracellular regulated protein kinases (ERK) and mitogen-activated protein kinase (MAPK)/P38 kinase.	Deferoxamine	25-28	mitogen-activated protein kinase 1	Mus musculus	225-228